chr12-9922069-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001130711.2(CLEC2A):c.303C>A(p.Asp101Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000723 in 1,382,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001130711.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLEC2A | NM_001130711.2 | c.303C>A | p.Asp101Glu | missense_variant | 3/5 | ENST00000455827.2 | NP_001124183.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLEC2A | ENST00000455827.2 | c.303C>A | p.Asp101Glu | missense_variant | 3/5 | 1 | NM_001130711.2 | ENSP00000396163 | P1 | |
CLEC2A | ENST00000339766.8 | c.303C>A | p.Asp101Glu | missense_variant | 3/5 | 1 | ENSP00000339732 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000687 AC: 1AN: 145472Hom.: 0 AF XY: 0.0000131 AC XY: 1AN XY: 76350
GnomAD4 exome AF: 7.23e-7 AC: 1AN: 1382998Hom.: 0 Cov.: 30 AF XY: 0.00000147 AC XY: 1AN XY: 681030
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.303C>A (p.D101E) alteration is located in exon 3 (coding exon 3) of the CLEC2A gene. This alteration results from a C to A substitution at nucleotide position 303, causing the aspartic acid (D) at amino acid position 101 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at